Concord Biotech Limited (CONCORDBIO) — Working Capital to Net Assets Ratio
Concord Biotech Limited (CONCORDBIO) has a Working Capital to Net Assets ratio of 50.6% as of September 2025. Working capital of Rs9.25 Billion (current assets of Rs10.80 Billion minus current liabilities of Rs1.55 Billion) is measured against net assets of Rs18.27 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See CONCORDBIO equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Concord Biotech Limited Working Capital to Net Assets (2020–2025)
This chart shows how Concord Biotech Limited's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of September 2025, the ratio stands at 50.6%, reflecting working capital of Rs9.25 Billion against net assets of Rs18.27 Billion INR. Check Concord Biotech Limited tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Concord Biotech Limited (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Concord Biotech Limited from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Concord Biotech Limited market capitalisation.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 52.5% | Rs9.51 Billion | Rs18.13 Billion | Rs11.35 Billion | Rs1.84 Billion | ▲ +3.1 pp |
| 2024 | 49.4% | Rs7.54 Billion | Rs15.27 Billion | Rs8.96 Billion | Rs1.42 Billion | ▲ +7.9 pp |
| 2023 | 41.5% | Rs5.36 Billion | Rs12.90 Billion | Rs7.28 Billion | Rs1.92 Billion | ▼ -1.7 pp |
| 2022 | 43.3% | Rs4.77 Billion | Rs11.03 Billion | Rs6.33 Billion | Rs1.55 Billion | ▼ -6.9 pp |
| 2021 | 50.2% | Rs5.01 Billion | Rs9.99 Billion | Rs6.07 Billion | Rs1.06 Billion | ▲ +59.2 pp |
| 2020 | -9.0% | Rs-694.75 Million | Rs7.70 Billion | Rs456.20 Million | Rs1.15 Billion | — |